Clinical Trials Browser

Phase 2 × surufatinib × NET × Clear all

NCT07357623 2026-01-22

Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors

Phase 2 Recruiting

Pulmonary Neuroendocrine Tumor

NCT04579679 2025-07-25

Open-Label Surufatinib in European Patients With NET

Phase 2 Terminated

78 enrolled 20 charts

Neuroendocrine Tumors

NCT05165407 2025-03-14

NESSIE

Phase 2 Recruiting

Neuroendocrine Tumors